69 related articles for article (PubMed ID: 15118371)
1. CCR4 Expression by atypical T cells in systemic pilotropic lymphoma: its behavior under treatment with interferon gamma, topical PUVA and systemic retinoid.
Fujimura T; Aiba S; Yoshino Y; Kuroki S; Kimura Y; Kikuchi K; Kunii T; Matsunaga J; Matsushima K; Tagami H
Dermatology; 2004; 208(3):221-6. PubMed ID: 15118371
[TBL] [Abstract][Full Text] [Related]
2. Interferon-alpha is effective for CD4(+), CCR4(-) mycosis fungoides.
Fujimura T; Okuyama R; Watabe A; Hashimoto A; Tagami H; Aiba S
Int J Dermatol; 2007 Apr; 46(4):435-8. PubMed ID: 17442093
[TBL] [Abstract][Full Text] [Related]
3. Juvenile mycosis fungoides treated with bexarotene and PUVA.
Rodríguez-Vázquez M; García-Arpa M; González-García J
Int J Dermatol; 2007 Jan; 46(1):99-102. PubMed ID: 17214731
[TBL] [Abstract][Full Text] [Related]
4. Production of thymus and activation-regulated chemokine and macrophage-derived chemokine by CCR4+ adult T-cell leukemia cells.
Shimauchi T; Imai S; Hino R; Tokura Y
Clin Cancer Res; 2005 Mar; 11(6):2427-35. PubMed ID: 15788694
[TBL] [Abstract][Full Text] [Related]
5. Bath-PUVA therapy decreases infiltrating CCR4-expressing tumor cells and regulatory T cells in patients with mycosis Fungoides.
Kato H; Saito C; Ito E; Furuhashi T; Nishida E; Ishida T; Ueda R; Inagaki H; Morita A
Clin Lymphoma Myeloma Leuk; 2013 Jun; 13(3):273-80. PubMed ID: 23332394
[TBL] [Abstract][Full Text] [Related]
6. Complete clinical remission of tumor-stage granulomatous mycosis fungoides after treatment with PUVA, skin electron irradiation, oral etretinate and systemic interferon-γ.
Yamada Y; Oka M; Fujiwara S; Nishioka E; Okamoto Y; Hayashibe K; Nishigori C
Int J Dermatol; 2013 Jul; 52(7):893-5. PubMed ID: 23789610
[No Abstract] [Full Text] [Related]
7. Circulating clonal CLA(+) and CD4(+) T cells in Sezary syndrome express the skin-homing chemokine receptors CCR4 and CCR10 as well as the lymph node-homing chemokine receptor CCR7.
Sokolowska-Wojdylo M; Wenzel J; Gaffal E; Lenz J; Speuser P; Erdmann S; Abuzahra F; Bowman E; Roszkiewicz J; Bieber T; Tüting T
Br J Dermatol; 2005 Feb; 152(2):258-64. PubMed ID: 15727636
[TBL] [Abstract][Full Text] [Related]
8. Bexarotene blunts malignant T-cell chemotaxis in Sezary syndrome: reduction of chemokine receptor 4-positive lymphocytes and decreased chemotaxis to thymus and activation-regulated chemokine.
Richardson SK; Newton SB; Bach TL; Budgin JB; Benoit BM; Lin JH; Yoon JS; Wysocka M; Abrams CS; Rook AH
Am J Hematol; 2007 Sep; 82(9):792-7. PubMed ID: 17546636
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of CCR4 expression in adult T-cell leukemia/lymphoma: its close association with skin involvement and unfavorable outcome.
Ishida T; Utsunomiya A; Iida S; Inagaki H; Takatsuka Y; Kusumoto S; Takeuchi G; Shimizu S; Ito M; Komatsu H; Wakita A; Eimoto T; Matsushima K; Ueda R
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3625-34. PubMed ID: 14506150
[TBL] [Abstract][Full Text] [Related]
10. Treatment of mycosis fungoides with oral bexarotene combined with PUVA.
Stern DK; Lebwohl M
J Drugs Dermatol; 2002 Sep; 1(2):134-6. PubMed ID: 12847736
[TBL] [Abstract][Full Text] [Related]
11. Chemokine receptor expression in cutaneous T cell and NK/T-cell lymphomas: immunohistochemical staining and in vitro chemotactic assay.
Yagi H; Seo N; Ohshima A; Itoh T; Itoh N; Horibe T; Yoshinari Y; Takigawa M; Hashizume H
Am J Surg Pathol; 2006 Sep; 30(9):1111-9. PubMed ID: 16931956
[TBL] [Abstract][Full Text] [Related]
12. Selective accumulation of CCR4+ T lymphocytes into renal tissue of patients with lupus nephritis.
Yamada M; Yagita H; Inoue H; Takanashi T; Matsuda H; Munechika E; Kanamaru Y; Shirato I; Tomino Y; Matushima K; Okumura K; Hashimoto H
Arthritis Rheum; 2002 Mar; 46(3):735-40. PubMed ID: 11920409
[TBL] [Abstract][Full Text] [Related]
13. Photochemotherapy (PUVA) in the tumour stage of mycosis fungoides: a report from the Scandinavian Mycosis Fungoides Study Group.
Molin L; Thomsen K; Volden G; Groth O
Acta Derm Venereol; 1981; 61(1):52-4. PubMed ID: 6164215
[TBL] [Abstract][Full Text] [Related]
14. O6-alkylguanine-DNA alkyltransferase in cutaneous T-cell lymphoma: implications for treatment with alkylating agents.
Dolan ME; McRae BL; Ferries-Rowe E; Belanich M; van Seventer GA; Guitart J; Pezen D; Kuzel TM; Yarosh DB
Clin Cancer Res; 1999 Aug; 5(8):2059-64. PubMed ID: 10473086
[TBL] [Abstract][Full Text] [Related]
15. Folliculotropic mycosis fungoides and a leonine clinical appearance of the face.
Ito T; Yamamoto T; Matsumoto Y; Wakamatsu J; Kato Y; Tsuboi R
Dermatol Online J; 2008 Sep; 14(9):6. PubMed ID: 19061588
[TBL] [Abstract][Full Text] [Related]
16. [Interferon-alpha and PUVA therapy for mycosis fungoides].
Marschalkó M; Kovács J; Somlai B; Berecz M; Hídvégi B; Hársing J; Désaknai M; Horváth A
Orv Hetil; 2001 Sep; 142(37):2021-3. PubMed ID: 11582733
[TBL] [Abstract][Full Text] [Related]
17. [Change of level of mycosis fungoides under systemic PUVA-therapy (author's transl)].
Tourbier H; Schultz-Ehrenburg U
Z Hautkr; 1981 Jul; 56(14):923-9. PubMed ID: 7269717
[TBL] [Abstract][Full Text] [Related]
18. A randomized cross-over study to compare PUVA and extracorporeal photopheresis in the treatment of plaque stage (T2) mycosis fungoides.
Child FJ; Mitchell TJ; Whittaker SJ; Scarisbrick JJ; Seed PT; Russell-Jones R
Clin Exp Dermatol; 2004 May; 29(3):231-6. PubMed ID: 15115499
[TBL] [Abstract][Full Text] [Related]
19. [Preliminary results of Re-PUVA therapy in cutaneous T-cell lymphomas].
Thiele B; Rasokat H; Mahrle G
Z Hautkr; 1985 Jan; 60(1-2):116-9. PubMed ID: 3872538
[TBL] [Abstract][Full Text] [Related]
20. Mycosis fungoides in a hemodialysis patient with intractable pruritus.
Miyoshi M; Ubara Y; Tagami T; Sawa N; Son D; Hoshino J; Katori H; Takemoto F; Hara S; Kishi A; Motoi N; Takaichi K
Ther Apher Dial; 2006 Jun; 10(3):296-300. PubMed ID: 16817798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
